Codes / ICD10CM / M62.59

M62.59 Muscle wasting and atrophy, not elsewhere classified, multiple sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Muscle wasting and atrophy, not elsewhere classified, multiple sites (ICD-10-CM: M62.59)

Summary

Muscle wasting and atrophy, not elsewhere classified, multiple sites refers to the loss of muscle mass and strength affecting multiple body areas without a specified underlying cause. This condition may result from various factors impacting muscle health, leading to reduced muscle function and potential functional impairment across affected regions.

Causes

Causes are diverse and may include disuse (e.g., immobility), systemic diseases, nutritional deficiencies, or underlying metabolic conditions. In some cases, the exact cause remains unidentified, and the condition may arise without a clear precipitating factor.

Risk Factors

  • Prolonged immobility or bed rest
  • Chronic illnesses affecting muscle metabolism
  • Malnutrition or inadequate protein intake
  • Certain medications (e.g., corticosteroids)
  • Advanced age
  • Neurological conditions affecting muscle control

Symptoms

  • Gradual loss of muscle mass or visible thinning in multiple areas
  • Reduced muscle strength or endurance across affected sites
  • Fatigue or difficulty with physical tasks involving multiple muscle groups
  • Possible changes in muscle tone or appearance in affected regions

Diagnosis

Diagnosis typically involves a physical examination to assess muscle mass and strength across multiple sites, patient history to identify potential contributing factors, and may include blood tests to evaluate nutritional or metabolic status. Imaging or electromyography may be used in select cases to rule out other conditions.

Treatment Options

Treatment focuses on addressing underlying causes, such as improving mobility, nutritional support, or managing chronic conditions. Physical therapy may help restore strength and function. In some cases, medications or other interventions may be considered based on the underlying etiology.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and response to treatment. Regular follow-up may be necessary to monitor muscle function and adjust management plans. Early intervention can improve outcomes, particularly when addressing reversible factors like immobility or malnutrition.

Complications

Potential complications include decreased functional independence, increased risk of falls, and reduced quality of life due to muscle weakness. Severe or prolonged atrophy may lead to permanent muscle loss or mobility limitations.

Lifestyle & Prevention

  • Maintain regular physical activity to support muscle health
  • Ensure adequate protein and nutrient intake
  • Address underlying chronic conditions promptly
  • Avoid prolonged immobility when possible
  • Consult healthcare providers for unexplained muscle changes

When to Seek Professional Help

Seek medical attention if you experience unexplained muscle wasting, significant weakness, or difficulty performing daily tasks. Prompt evaluation is important to identify and address potential underlying causes.

Tips for Medical Coders

Document the specific sites of muscle wasting and atrophy, as well as any identified contributing factors, to support accurate coding. Ensure clinical documentation aligns with the "not elsewhere classified" designation, confirming that the condition does not fit a more specific code. Verify that the multiple-site involvement is clearly noted to justify the use of M62.59.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

M62.59 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.